Argonaut And Akoya Expand Partnership For IVD Assay Manufacturing

Argonaut Manufacturing Services is a leading contract development and manufacturing organisation serving the biopharma and life sciences industries, and Akoya Biosciences, Inc. The manufacturing agreement links Argonaut with Akoya Biosciences Inc., The Spatial Biology Company®, to produce IVD assays that Akoya is developing. Argonaut and Akoya worked together for many years just before entering this agreement, demonstrating Argonaut's track record of supporting diagnostic product lines from emergence through maturity. This broadened partnership demonstrates these companies' shared dedication to advancing precision medicine advancements through superior diagnostic solutions. 

Wayne Woodard, Founder and CEO of Argonaut, commented, “Argonaut and Akoya have built a trusted relationship over the years. We’ve successfully supported their Research Use Only (RUO) portfolio and are thrilled to extend this partnership into the highly regulated companion diagnostic space. Akoya’s innovative solutions in spatial biology are shaping the future of precision medicine, and we are proud to play a role in bringing their vision to life.“

He also said, “Companion diagnostics are a cornerstone of Argonaut’s commitment to regulated markets, especially in light of evolving FDA requirements. Our agile manufacturing systems empower organisations like Akoya to reliably and efficiently scale their IVD offerings, helping them meet the growing demand for precision medicine solutions.”

“Our spatial phenotyping technology and PhenoImager platform demonstrate robust diagnostic capabilities for patient selection. Our partnership with Argonaut centres on delivering high-quality IVD products to our clients manufactured under strict cGMP and ISO 13485:2016 requirements. Argonaut’s deep expertise and reliable systems make them an invaluable partner as we scale to meet the market's demand,” commented Brian McKelligon, CEO of Akoya.